Pancreatic cancer. Molecular and surgical pathology;Pankreaskarzinom Molekulare und chirurgische Pathologie

Pathologe

Volumn 31, Issue SUPPL. 2, 2010, Pages 225-228

  Tannapfel, A ^a  

^a INSTITUT FÜR PATHOLOGIE   (Germany)

Author keywords

Hereditary tumor syndromes; Molecular alterations; Pancreatic adenocarcinoma; Pathology; R classification

Indexed keywords

TUMOR MARKER;

ARTICLE; CANCER STAGING; GENETICS; HUMAN; LYMPH NODE; MINIMAL RESIDUAL DISEASE; PANCREAS; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PATHOLOGY; PROGNOSIS;

CARCINOMA, PANCREATIC DUCTAL; HUMANS; LYMPH NODES; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PANCREAS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79953221912     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-010-1298-x     Document Type: Article

References (17)

1. Robert-Koch-Institut-Krebsregisterdaten 2010. http://www.rki.de/cln-178/ nn-205770/sid-09AABD10ECC4BDD34786E9DF696FE7C1/DE/Content/GBE/DachdokKrebs/ krebs-node.html?-nnn=true
2. AWMF-Leitlinie: Exokrines Pankreaskarzinom. http://www.leitlinien.net/
3. Shi C, Daniels JA, Hruban RH (2008) Molecular characterization of pancreatic neoplasms. Adv Anat Pathol 15:185-195
4. Jones S, Zhang X, Parsons DW et al (2008) Core signalling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801-1806
5. Hruban RH, Adsay NV, Albores-Saavedra J et al (2001) Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 25:579-586
6. Blackford A, Parmigiani G, Kensler TW et al (2009) Genetic mutations associated with cigarette smoking in pancreatic cancer. Cancer Res 69:3681-3688
7. Raimondi S, Lowenfels AB, Morselli-Labate AM et al (2010) Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 24:349-358
8. Hidalogo M (2010) Pancreatic cancer. N Engl J Med 362:1605-1617
9. Chu D, Kohlmann W, Adler DG (2010) Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromes. JOP 11:203-212
10. Alexakis N, Halloran C, Raraty M et al (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91:1410-1427
11. Wittekind C, Meyer HJ (2010) TNM Klassifikation maligner Tumore. Wiley-VCH, Weinheim
12. Verbeke CS (2008) Resection margins and R1 rates in pancreatic cancer-are we there yet? Histopathology 52:787-796
13. Raut CP, Tseng JF, Sun CC et al (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246:52-60
14. Campbell F, Smith RA, Whelan P et al (2009) Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin. Histopathology 55:277-283
15. Fietkau R, Heinemann V, Oettle H et al (2010) New data on pancreatic cancer. Onkologie 33 (Suppl 4):31-35
16. Chang DK, Johns AL, Merrett ND et al (2009) Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol 27:2855-2862
17. Menon KV, Gomez D, Smith AM et al (2009) Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB (Oxford) 11:18-24